Related Experiment Video
Updated: Aug 16, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
SH2 Domains: Folding, Binding and Therapeutical Approaches
Awa Diop1, Daniele Santorelli1, Francesca Malagrinò1
1Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy.
Src Homology 2 (SH2) domains are crucial for cell signaling via phosphotyrosine binding. Understanding their stability and binding is key to developing new therapeutics for SH2-related diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- Src Homology 2 (SH2) domains mediate critical protein-protein interactions (PPIs) by recognizing phosphorylated tyrosine residues.
- Phosphotyrosine modification is a key regulator of eukaryotic cellular pathways, highlighting the fundamental role of SH2 domains in cell signaling.
- Dysregulation of SH2 domain-mediated PPIs is implicated in various human pathologies.
Purpose of the Study:
- To review current knowledge on the structural, folding stability, and binding properties of SH2 domains.
- To elucidate the roles of SH2 domains in molecular pathways and pathogenesis.
- To explore strategies for modulating or inhibiting SH2 domain binding for therapeutic purposes.
Main Methods:
- Literature review of structural, biophysical, and biochemical studies on SH2 domains.
- Analysis of SH2 domain involvement in cellular signaling and disease mechanisms.
- Examination of diverse approaches for targeting SH2 domain interactions.
Main Results:
- SH2 domains are well-characterized PPI modules essential for signal transduction.
- Their structural and binding properties are intrinsically linked to their function in physiological and pathological processes.
- Various strategies exist to modulate SH2 domain binding, indicating therapeutic potential.
Conclusions:
- Pharmacological targeting of SH2 domains presents a strategic avenue for novel therapeutic development.
- A comprehensive understanding of SH2 domain thermodynamic stability and binding determinants is crucial for preventing dysregulated interactions and improving therapeutic efficacy.
More Related Videos
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Molecular Chaperones and Protein Folding
The...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Protein Folding
Ligand Binding and Linkage

